Dr. Cheryl Ho, MD
Claim this profileBC Cancer
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
5 reported clinical trials
6 drugs studied
Area of expertise
1Lung Cancer
Stage IV
EGFR positive
Stage III
2Non-Small Cell Lung Cancer
Stage IV
EGFR positive
Stage III
Affiliated Hospitals
Clinical Trials Cheryl Ho, MD is currently running
Targeted Therapy
for Advanced Rare Cancers
This pilot clinical trial aims to assess the real world quality of life and survival of patients treated with targeted therapy that has preliminary evidence of efficacy in subjects with advanced rare cancers or cancer harbouring rare molecular aberrations. The treatment has been granted conditional or full approved by Health Canada (HC) as effective and safe. Due to the rarity of the cancer or molecular aberration the uncertainty level of the health technology assessment (HTA) by the pan Canadian Oncology Review (pCODR) was too high for consideration of funding or it was not submitted for consideration. Consequently, the goal of this study is to generate real world evidence to support HTA decision making throughout the life cycle of the product.
Recruiting1 award N/A7 criteria
Pembrolizumab
for Lung Cancer
BR36 will evaluate the potential clinical benefit of tailoring immunotherapy treatment based on ctDNA molecular response in non-small cell lung cancer.
Recruiting1 award Phase 2 & 318 criteria
More about Cheryl Ho, MD
Clinical Trial Related4 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Cheryl Ho, MD has experience with
- Osimertinib
- Stereotactic Radiotherapy
- FoundationOne Liquid CDx
- Targeted Therapy
- Lumbar Puncture And Phlebotomy
- Pembrolizumab
Breakdown of trials Cheryl Ho, MD has run
Lung Cancer
Non-Small Cell Lung Cancer
Brain Tumor
Leptomeningeal Carcinomatosis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Cheryl Ho, MD specialize in?
Cheryl Ho, MD focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are EGFR positive.
Is Cheryl Ho, MD currently recruiting for clinical trials?
Yes, Cheryl Ho, MD is currently recruiting for 3 clinical trials in Vancouver British Columbia. If you're interested in participating, you should apply.
Are there any treatments that Cheryl Ho, MD has studied deeply?
Yes, Cheryl Ho, MD has studied treatments such as Osimertinib, Stereotactic Radiotherapy, FoundationOne liquid CDx.
What is the best way to schedule an appointment with Cheryl Ho, MD?
Apply for one of the trials that Cheryl Ho, MD is conducting.
What is the office address of Cheryl Ho, MD?
The office of Cheryl Ho, MD is located at: BC Cancer, Vancouver, British Columbia V5Z4E6 Canada. This is the address for their practice at the BC Cancer.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.